Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2025
Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy
Teresa Amaral, Eftychia Chatziioannou, Alica Nuebling, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 4, 2023
Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP)
Teresa Amaral, Tobias Sinnberg, Eftychia Chatziioannou, et al.
Cancers
|
August 23, 2020
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients
Franz J Hilke, Tobias Sinnberg, Axel Gschwind, et al.
Molecular Cancer Research : MCR
|
May 11, 2018
YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT
Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
The American Journal of Pathology
|
July 18, 2020
Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic Tumors
Maximilian Gassenmaier, Maximilian Rentschler, Birgit Fehrenbacher, et al.
Ebiomedicine
|
July 19, 2016
A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib
Tobias Sinnberg, Elena Makino, Marcel A Krueger, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
November 21, 2018
6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells
Sascha Venturelli, Heike Niessner, Tobias Sinnberg, et al.
American Journal of Clinical Dermatology
|
May 4, 2023
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy
Eftychia Chatziioannou, Ulrike Leiter, Ioannis Thomas, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 23, 2024
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy
Francisco Meraz-Torres, Heike Niessner, Sarah Plöger, et al.
Cancers
|
March 1, 2020
MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma
Andrea Forschner, Franz-Joachim Hilke, Irina Bonzheim, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2025
Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy
Teresa Amaral, Eftychia Chatziioannou, Alica Nuebling, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 4, 2023
Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP)
Teresa Amaral, Tobias Sinnberg, Eftychia Chatziioannou, et al.
Cancers
|
August 23, 2020
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients
Franz J Hilke, Tobias Sinnberg, Axel Gschwind, et al.
Molecular Cancer Research : MCR
|
May 11, 2018
YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT
Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
The American Journal of Pathology
|
July 18, 2020
Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic Tumors
Maximilian Gassenmaier, Maximilian Rentschler, Birgit Fehrenbacher, et al.
Ebiomedicine
|
July 19, 2016
A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib
Tobias Sinnberg, Elena Makino, Marcel A Krueger, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
November 21, 2018
6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells
Sascha Venturelli, Heike Niessner, Tobias Sinnberg, et al.
American Journal of Clinical Dermatology
|
May 4, 2023
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy
Eftychia Chatziioannou, Ulrike Leiter, Ioannis Thomas, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 23, 2024
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy
Francisco Meraz-Torres, Heike Niessner, Sarah Plöger, et al.
Cancers
|
March 1, 2020
MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma
Andrea Forschner, Franz-Joachim Hilke, Irina Bonzheim, et al.
Page
of 6